In our study, we identified a 37-gene TAM signature that is highly expressed in the most aggressive breast cancer subtypes and enriched in a CSF1-high group that has been previously associated with higher tumor grade, decreased expression of ER and PR, and higher mutation rate (Beck et al., 2009). The gene discussed is ESR1; the disease is neoplasm.